Prudential Financial’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$165K Buy
60,330
+25,700
+74% +$81.4K ﹤0.01% 2170
2025
Q4
$128K Sell
34,630
-9,080
-21% -$29.3K ﹤0.01% 2105
2025
Q3
$116K Buy
43,710
+14,500
+50% +$28K ﹤0.01% 2267
2025
Q2
$28.7K Buy
29,210
+2,870
+11% +$2.87K ﹤0.01% 2377
2025
Q1
$37.9K Sell
26,340
-7,230
-22% -$13.3K ﹤0.01% 2219
2024
Q4
$73.9K Sell
33,570
-16,000
-32% -$37.3K ﹤0.01% 2174
2024
Q3
$81.8K Buy
49,570
+2,600
+6% +$5.25K ﹤0.01% 2598
2024
Q2
$104K Buy
46,970
+14,910
+47% +$35.1K ﹤0.01% 2541
2024
Q1
$85.9K Sell
32,060
-1,200
-4% -$2.92K ﹤0.01% 2541
2023
Q4
$99.4K Hold
33,260
﹤0.01% 2502
2023
Q3
$32.6K Buy
+33,260
New +$48.1K ﹤0.01% 2542
2020
Q1
Sell
-3,683
Closed -$220K 2381
2019
Q4
$220K Buy
+3,683
New +$166K ﹤0.01% 2308

Other funds holding ESPR